Acer Therapeutics Inc
ACER
ACER was delisted on the 8th of November, 2023.
31 hedge funds and large institutions have $3.4M invested in Acer Therapeutics Inc in 2023 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 6 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 4
50% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 6
47% more capital invested
Capital invested by funds: $2.32M → $3.4M (+$1.08M)
11% more funds holding
Funds holding: 28 → 31 (+3)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $49K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
+$815K |
| 2 |
Tudor Investment Corp
Stamford,
Connecticut
|
+$762K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$239K |
| 4 |
HF
HRT Financial
New York
|
+$66.4K |
| 5 |
VF
Virtu Financial
New York
|
+$50.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$253K |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$179K |
| 3 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$120K |
| 4 |
Renaissance Technologies
New York
|
-$95K |
| 5 |
Goldman Sachs
New York
|
-$81.3K |
ACER Hedge Fund Activity: Q3 2023 in Review
31 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q3 2023, worth a combined $3.4M — up 47% from $2.32M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new ACER positions and 6 closed out — a net gain of 3 holders — while 8 added to existing stakes and 4 trimmed.
The largest buyer was Yakira Capital Management, opening a new position worth an estimated $815K. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $253K sold.
- 31 institutional investors held Acer Therapeutics Inc (ACER) as of Q3 2023, up from 28 in Q2 2023.
- Funds reported $3.4M of Acer Therapeutics Inc stock for Q3 2023, up 47% quarter-over-quarter.
- 9 funds opened new Acer Therapeutics Inc positions in Q3 2023 and 6 closed out, a net change of +3 holders.
- The largest Acer Therapeutics Inc buyer in Q3 2023 was Yakira Capital Management, an estimated $815K added.
- The largest Acer Therapeutics Inc seller in Q3 2023 was Hudson Bay Capital Management, an estimated $253K sold.
Based on aggregated 13F filings for Q3 2023.